Therapeutic targeting of oxygen-sensing prolyl hydroxylases abrogates ATF4-dependent neuronal death and improves outcomes after brain hemorrhage in several rodent models.
Science Translational Medicine.
Times cited: 21
Inhibition of 12/15-lipoxygenase as therapeutic strategy to treat stroke.
Annals of Neurology.
Times cited: 39